UBS maintains Atour Lifestyle Holdings Buy rating as retail revenue guidance is raised as expected

Overview

This report is UBS's commentary on Atour Lifestyle Holdings' Q1 2026 results. The company's revenue and adjusted net profit were Rmb2.8bn and Rmb490mn, respectively, representing year-over-year growth of 47.5% and 42%, in line with UBS and market expectations. The report emphasizes that the retail revenue guidance increase was as expected, the shareholder return target is clear, and the current valuation remains attractive relative to the target price.

Core views

UBS maintains its Buy rating on ATAT.US and its US$51.50 target price. The core view is: first, Q1 2026 results were not meaningfully below expectations, with both revenue and profit sustaining high growth; second, the company's retail business grew better than expected and is the main potential source of future EPS upgrades or upside surprises; third, the company maintains its dividend plus buyback 100% payout ratio target, improving the visibility of shareholder returns; and fourth, the current 16.8x 2026E PE is below the 23.8x 2026E PE implied by the target price, leaving room for valuation upside.

Analysis framework

The report combines an earnings review, profit forecasts, valuation multiples, shareholder returns, and scenario-based questionnaire judgments. UBS compares the company's actual Q1 2026 revenue and adjusted net profit with its own and market expectations, supports the target price with a DCF method, and uses Forecast Stock Return relative to Market Return Assumption to explain the Buy rating.

Methodology notes

• Valuation methodsDCF

  Discounted cash flow valuation

  UBS states that Atour's target price is based on DCF, supporting the 12-month US$51.50 target price through discounted future cash flows.

• rating_frameworkForecast Stock Return vs Market Return Assumption

  Forecast stock return relative to market return assumption

  UBS defines Forecast Stock Return as the expected price appreciation plus dividend yield over the next 12 months; Market Return Assumption is the local one-year interest rate plus 5%. A Buy rating requires FSR to be at least 6% above MRA.

• earnings_analysisEPS forecast comparison

  Comparison of earnings forecasts with consensus

  The visible forecast table shows UBS 2026E to 2028E diluted EPS of approximately Rmb15.56, Rmb19.53, and Rmb24.85, respectively, above visible consensus, and this estimate was essentially unchanged in this report.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• ATAT.US

  covered_company

  Strengths

  Q1 2026 revenue and profit both grew strongly year over year and came in as expected; retail business growth is seen as an upside driver; the company maintains its dividend plus buyback 100% payout ratio target; the target price implies considerable upside.

  Weaknesses

  The report discloses that the current free float is only 4%, which may affect trading liquidity and share price volatility; the current valuation still depends on strong growth and future earnings delivery.

  Comparison

  The company currently trades at about 16.8x 2026E PE, below the 23.8x 2026E PE implied by UBS's target price; UBS's 2026E to 2028E EPS forecasts are above visible consensus.

  Risks

  Retail business growth falling short of expectations, deterioration in hotel demand, valuation multiple compression, foreign exchange fluctuations, regulatory risk, or market liquidity risk.

Key data

• Q1 2026 revenueRmb2.8bnUp 47.5% year over year, in line with UBS and market expectations.
• Q1 2026 adjusted net profitRmb490mnUp 42% year over year, in line with UBS and market expectations.
• Cash dividendabout US$72mnThe company plans to maintain a future dividend plus buyback 100% payout ratio target.
• 12-month ratingBuyUBS maintains a Buy rating.
• Target priceUS$51.50Unchanged, implying 23.8x 2026E PE.
• Current priceUS$37.61The price date in the disclosure table is 2026-05-13.
• Current valuation16.8x 2026E PEUBS believes there is still substantial valuation upside relative to the target price.
• Forecast price upside34.3%From the disclosed forecast returns.
• Forecast dividend yield2.7%From the disclosed forecast returns.
• Forecast total stock return36.9%Above the 10.9% market return assumption, implying a 26.1% forecast excess return.
• 2026E revenueRmb12,216mnHighlighted forecast column in UBS.
• 2026E diluted EPSRmb15.56UBS forecast, and the table shows it is broadly unchanged from the prior estimate.

Impact & implications

The investment implication for ATAT.US is positive: delivery on earnings, retail business growth, shareholder returns, and valuation upside all support the Buy rating. If retail business continues to outperform expectations, EPS and market sentiment may benefit; if hotel demand or consumer conditions weaken, revenue growth and the valuation rerating logic could be undermined.

Risks

• If retail business growth is weaker than expected, EPS upside risk and the valuation rerating logic may be weakened.
• A deterioration in hotel industry demand or competition could affect revenue growth and profit margins.
• DCF valuation depends on assumptions about long-term growth, margins, and discount rates, and different assumptions could materially change the target price.
• The ADR and US dollar-denominated asset may be affected by exchange rates, cross-border regulation, and market sentiment.
• The disclosure indicates UBS may have provided or received investment banking-related compensation from the company over the past 12 months; investors should watch for potential conflicts of interest.

What to watch

• Whether subsequent retail business revenue growth continues to outperform expectations.
• Whether 2026E EPS can meet or exceed UBS's Rmb15.56 forecast.
• Whether the company continues to execute its dividend plus buyback 100% payout ratio target.
• Whether the valuation gap between the US$51.50 target price and the current price narrows through earnings delivery or market rerating.
• Whether the industry structure and regulatory environment continue to improve or remain stable over the next six months.